The Division of Hematology and Oncology is the largest subspecialty unit within the Department of Internal Medicine. Our faculty, staff, students, and laboratory personnel occupy space in seven locations on the medical campus, including the Michigan Medicine Rogel Cancer Center. We are highly committed to excellence in patient care, teaching, and research for cancer and hematologic disorders.
We care for patients with benign and malignant disorders of the blood and lymphatic organs, as well as for patients with most types of solid tumor malignancies. We have dedicated coagulation, hemophilia and thrombosis clinics, plus multiple experts in myeloproliferative disorders. In addition, we have numerous state-of-the-art specialty clinics and programs at the Rogel Cancer Center to evaluate, diagnose, treat, and manage cancer and hematologic disorders, along with several support programs for patients and their families.
We pride ourselves on being on the leading edge of research, and are dedicated to providing our patients with the very best care and treatment. Our faculty are involved in bench to bedside research, from basic laboratory experiments to conducting experimental clinical treatments, with the goal of providing better treatment options for patients with cancer and hematologic disorders. Our division has been extremely successful in obtaining awards and grants to support our research interests.
Our Hematology/Oncology Fellowship Training Program combines well-rounded clinical training with the opportunities to work with world-class investigators in a collegial environment. Additionally, many of our faculty are involved in the education of students interested in scientific research careers through a number of different programs, and also establish both formal and informal mentorship relationships with undergraduate, graduate, and post-doctoral students.